Skip to content
10-Q

Quarterly Report

HUBEI MINKANG PHARMACEUTICAL LTD.

0001477932-14-002802

← back to feed
Filed
May 20, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · May 15, 2014 52.19M sh
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$888.58K
Operating Cash Flow Q1 2014 · Mar 31, 2013 −$1.05M
Stockholders Equity Q1 2014 · Mar 31, 2014 $11.25M
Stockholders Equity Q1 2014 · Dec 31, 2013 $11.43M
Stockholders Equity Q1 2014 · Dec 31, 2012 $10.95M
Current Liabilities Q1 2014 · Mar 31, 2014 $9.25M
Current Liabilities Q1 2014 · Dec 31, 2013 $10.19M
Total Liabilities Q1 2014 · Mar 31, 2014 $9.25M
Total Liabilities Q1 2014 · Dec 31, 2013 $10.19M
Current Assets Q1 2014 · Mar 31, 2014 $13.7M
Current Assets Q1 2014 · Dec 31, 2013 $14.6M
Total Assets Q1 2014 · Mar 31, 2014 $20.5M
Total Assets Q1 2014 · Dec 31, 2013 $21.62M
Sga Expense Q1 2014 · Mar 31, 2014 $699.56K
Sga Expense Q1 2014 · Mar 31, 2013 $744.74K
Rd Expense Q1 2014 · Mar 31, 2014 $9.21K
Rd Expense Q1 2014 · Mar 31, 2013 $11.31K
Net Income Q1 2014 · Mar 31, 2014 −$82.28K
Net Income Q1 2014 · Dec 31, 2013 $127.27K
Net Income Q1 2014 · Mar 31, 2013 −$286.24K
Operating Income Q1 2014 · Mar 31, 2014 −$96.75K
Operating Income Q1 2014 · Mar 31, 2013 −$250.09K
Gross Profit Q1 2014 · Mar 31, 2014 $1.21M
Gross Profit Q1 2014 · Mar 31, 2013 $1.11M
Revenue Q1 2014 · Mar 31, 2014 $2.89M
Revenue Q1 2014 · Mar 31, 2013 $2.73M
Cash And Equivalents Q1 2014 · Dec 31, 2013 $6.23M
Cash And Equivalents Q1 2014 · Dec 31, 2012 $6.07M
Capex Q1 2014 · Mar 31, 2013 $40.62K